Jin Seon-Ah, Seo Hee Jung, Kim Sun Kyeong, Lee Yu Ran, Choi Sunga, Ahn Kye-Taek, Kim Jun-Hyung, Park Jae-Hyeong, Lee Jae-Hwan, Choi Si Wan, Seong In-Whan, Jeon Byeong Hwa, Jeong Jin-Ok
Divison of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
Department of Physiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
Korean Circ J. 2015 Sep;45(5):364-71. doi: 10.4070/kcj.2015.45.5.364. Epub 2015 Apr 22.
Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) is a multifunctional protein involved in the DNA base excision repair pathway, inflammation, angiogenesis, and survival pathways. We investigated serum APE1/Ref-1 in patients with coronary artery disease (CAD).
Serum APE1/Ref-1 was measured with a sandwich enzyme-linked immunosorbent assay from 360 patients who received coronary angiograms. They were divided into two groups; a control (n=57) and a CAD group (n=303), the latter included angina (n=128) and myocardial infarction (MI, n=175).
The levels of APE1/Ref-1 were higher in the CAD than the control (0.63±0.07 vs. 0.12±0.07 ng/100 µL, respectively; p<0.01). They were also higher in MI than angina (0.81±0.10 vs. 0.38±0.11 ng/100 µL, respectively; p<0.01) and different according to the thrombolysis in myocardial infarction (TIMI) flow (0.88±0.09 for TIMI flow 0, 1, 2 vs. 0.45±0.13 ng/100 µL for TIMI flow 3, p<0.01) in acute coronary syndrome. In correlation analysis, the levels of APE1/Ref-1 were positively correlated with Troponin I (r=0.222; p<0.0001) and N-terminal pro-B type natriuretic peptide (NT-proBNP, r=0.217; p<0.0001) but not high sensitivity to C-reactive protein. Also, they revealed a negative correlation with ejection fraction (EF, r=-0.221; p=0.002). However, there were no significant differences among the three groups, were divided by their levels of APE1/Ref-1, for major adverse cardiovascular events (death, recurrent MI, stroke, revascularization) (8.2 vs. 14.0 vs. 12.5%, p=ns).
The levels of serum APE1/Ref-1 are elevated in CAD, and are higher in MI than in angina. They are correlated with Troponin I, NT-proBNP, and EF.
脱嘌呤/脱嘧啶内切酶1/氧化还原效应因子-1(APE1/Ref-1)是一种多功能蛋白,参与DNA碱基切除修复途径、炎症、血管生成和生存途径。我们研究了冠状动脉疾病(CAD)患者血清中的APE1/Ref-1。
采用夹心酶联免疫吸附测定法检测360例行冠状动脉造影患者的血清APE1/Ref-1。他们被分为两组,一组为对照组(n = 57),另一组为CAD组(n = 303),后者包括心绞痛患者(n = 128)和心肌梗死(MI)患者(n = 175)。
CAD组患者的APE1/Ref-1水平高于对照组(分别为0.63±0.07与0.12±0.07 ng/100 μL;p<0.01)。MI患者的APE1/Ref-1水平也高于心绞痛患者(分别为0.81±0.10与0.38±0.11 ng/100 μL;p<0.01),并且在急性冠状动脉综合征中,根据心肌梗死溶栓(TIMI)血流情况有所不同(TIMI血流0、1、2级时为0.88±0.09,TIMI血流3级时为0.45±0.13 ng/100 μL,p<0.01)。在相关性分析中,APE1/Ref-1水平与肌钙蛋白I(r = 0.222;p<0.0001)和N端前脑钠肽(NT-proBNP,r = 0.217;p<0.0001)呈正相关,但与高敏C反应蛋白无相关性。此外,它们与射血分数(EF,r = -0.221;p = 0.002)呈负相关。然而,根据APE1/Ref-1水平分为三组的患者,在主要不良心血管事件(死亡、再发心肌梗死、中风、血运重建)方面无显著差异(8.2%对14.0%对12.5%,p = 无统计学意义)。
CAD患者血清APE1/Ref-1水平升高,MI患者高于心绞痛患者。它们与肌钙蛋白I、NT-proBNP和EF相关。